Norbert W. Bischofberger, EVP, R&D and CSO at GILEAD SCIENCES INC (GILD), sold 90,000 shares at $80.24 ($7.3M) on 2014-05-14, disclosed to the SEC on 2014-05-16.
Scheduled sale ($7.3M) by EVP, R&D and CSO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $80.24 | 48,664 | $3.9M | 53.8% |
| 2 | $81.14 | 41,336 | $3.4M | 46.2% |
| Total | $80.65 avg | 90,000 | $7.3M | 100% |
| Filing → |
| KRON | BUY | 2023-11-17 | $2.7M | — | Filing → |
| KRON | BUY | 2022-05-19 | $3.4M | — | Filing → |
| KRON | BUY | 2021-12-08 | $347K | — | Filing → |